Gd-DTPA-loaded PLGA microbubbles as both ultrasound contrast agent and MRI contrast agent - A feasibility research

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 93, Issue 2, 2010, Pages 551-556

  Ao, Meng ^a   Wang, Zhigang ^a   Ran, Haitao ^a   Guo, Dajing ^a   Yu, Jinhong ^a   Li, Ao ^a   Chen, Weijuan ^a   Wu, Wei ^a   Zheng, Yuanyi ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Gadolinium; Magnetic resonance imaging; PLGA; Ultrasound contrast agent

Indexed keywords

CONTRAST AGENT; DIETHYLENETRIAMINE PENTA-ACETIC ACIDS; DOUBLE EMULSIONS; GD-DTPA; HIGH MOLECULAR WEIGHT; IN-VIVO IMAGING; KIDNEY FUNCTION; LOADING CAPACITIES; MEAN DIAMETER; MICROBUBBLES; MR IMAGES; MRI CONTRAST AGENTS; PLGA; PLGA MICROPARTICLES; POLY(LACTIC-CO-GLYCOLIC ACID); SIGNAL INTENSITIES; ULTRASOUND CONTRAST AGENT; ULTRASOUND ECHO; ULTRASOUND IMAGING; UP PERIOD;

ACIDS; EMULSIFICATION; INDUSTRIAL POISONS; LIVER; MAGNETIC RESONANCE; MAGNETIC RESONANCE IMAGING; SCANNING ELECTRON MICROSCOPY; ULTRASONIC TRANSMISSION; ULTRASONICS;

GADOLINIUM;

ECHO CONTRAST MEDIUM; FLUOROCARBON; GADOLINIUM PENTETATE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; POLYGLACTIN;

ANIMAL EXPERIMENT; ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; ECHOGRAPHY; EMULSION; ENCAPSULATION; FEASIBILITY STUDY; IMAGE ENHANCEMENT; IN VIVO STUDY; INJECTION; KIDNEY FUNCTION; LIVER BLOOD VESSEL; LIVER FUNCTION; LIVER PARENCHYMA; MICROBUBBLE; MORPHOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTICLE SIZE; RABBIT;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; PARTICLE SIZE; RABBITS; ULTRASONOGRAPHY;

EID: 77951159853     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31614     Document Type: Article

References (31)

1. Cosgrove D. Ultrasound contrast agents: An overview. Eur J Radiol 2006;60:324-330.
2. Ajit R, Anthony ND. Physical principles of microbubble ultrasound. Am J Cardiol 2002;90:3J-7J.
3. Wheatley MA, Singhal S. Structural studies on stabilized microbubbles: Development of a novel contrast agent for diagnostic ultrasound. Reactive Polym 1995;25:157-166.
4. Padma N, Darrell M, Margaret AW. Optimization of spray drying by factorial design for production of hollow microspheres for ultrasound imaging. J Biomed Mater Res 2001;56:333-341.
5. Portet TR, Xie F, Li S, D'sa A, Rafter P. Increased ultrasound contrast and decreased microbubble destruction rates with triggered ultrasound imaging. J Am Soc Echocardiogr 1996;9:599-605.
6. Porter TR, Li S, Jiang L, Grayburn P, Deligonul U. Real-time visualization of myocardial perfusion and wall thickening in human beings with intravenous ultrasonographic contrast and accelerated intermittent harmonic imaging. J Am Soc Echocardiogr 1999;12:266-271. (Pubitemid 29186144)
7. Oh JE, Nam YS, Lee KH, Park TG. Conjugation of drug to poly(D,Llactic-co-glycolic acid) for controlled release from biodegradable microspheres. J Control Release 1999;57:269-280.
8. Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997;28:5-24.
9. Straub JA, Chickering DE, Church CC, Shah B, Hanlon T, Bernstein H. Porous PLGA microparticles: AI-700, an intravenously administered ultrasound contrast agent for use in echocardiography. J control Release 2005;108:21-32. (Pubitemid 41476671)
10. Yao J, Takeuchi M, Teupe C, Sheahan M, Connolly R, Walovitch RC, Fetterman RC, Church CC, Udelson JE, Pandian NG. Evaluation of a new ultrasound contrast agent (AI-700) using two-dimensional and three-dimensional imaging during acute ischemia. J Am Soc Echocardiogr 2002;15:686-694. (Pubitemid 44964495)
11. Zotz RI, Schenk S, Kuhn A, Schlünken S, Krone V, Bruns W, Genth S, Schuler G. Safety and efficacy of LK565-A new polymer ultrasound contrast medium. Z Kardiol 2001;90:419-426. (Pubitemid 32641860)
12. Geisler T, Rost HC, Wild PS, Zotz R. Freehand three-dimensional assessment of left ventricular volumes and ejection fraction with ultrasound contrast agent LK565. Eur J Echocardiogr 2007;8:19-29. (Pubitemid 46126691)
13. Eniola AO, Hammer DA. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: Effect of degradation on targeting activity. Biomaterials 2005;26: 661-670.
14. Borselli C, Ungaro F, Oliviero O, d'Angelo I, Quaglia F, La Rotonda MI, Netti PA. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J Biomed Mater Res A 2010;92:94-102.
15. Beekman F, Hutton BF. Multi-modality imaging on track. Eur J Nucl Med Mol Imaging 2007;34:1410-1414.
16. Beyer T, Pietrzyk U, Knoess C, Vollmar S, Wienhard K, Kracht L, Bockisch A, Maderwald S, Kühl H, Fitzek M. Multi-modality imaging of uveal melanomas using combined PET/CT, high-resolution PET and MR imaging. Nuklearmedizin 2008;47:73-79. (Pubitemid 351700465)
17. Rouse HC, Godoy MC, Lee WK, Phang PT, Brown CJ, Brown JA. Imaging findings of unusual anorectal and perirectal pathology: A multi-modality approach. Clin Radiol 2008;63:1350-1360.
18. Sinha SP, Roubidoux MA, Helvie MA, Nees AV, Goodsitt MM, LeCarpentier GL, Fowlkes JB, Chalek CL, Carson PL. Multi-modality 3D breast imaging with X-Ray tomosynthesis and automated ultrasound. Conf Proc IEEE Eng Med Biol Soc 2007;2007:1335-1338.
19. van Dalen JA, Vogel WV, Corstens FH, Oyen WJ. Multi-modality nuclear medicine imaging: Artefacts, pitfalls and recommendations. Cancer Imaging 2007;7:77-83.
20. Tops LF, van der Wall EE, Schalij MJ, Bax JJ. Multi-modality imaging to assess left atrial size, anatomy and function. Heart 2007;93:1461-1470.
21. Li YL, Jin YG. Multi-mode imaging system. Beijing Biomed Eng 2000;3:110-112.
22. Wang XM, Chen L. Advancement of the clinical applications of imaging fusion. Chinese Med Abstract: Tumor 2008;163-164:167.
23. Yang Y, Wang ZG, Zheng YY, Zhu YF, Zhang Y. Experimental study of lipid perfluorooctylbromide nanoparticles ultrasound contrast agent in enhanced computed tomography of rats. Chinese J Med Imaging Technol 2008;24:1341-1344.
24. Yang F, Li Y, Chen Z, Zhang Y, Wu J, Gu N. Superparamagnetic iron oxide nanoparticle-embedded encapsulated microbubbles as dual contrast agents of magnetic resonance and ultrasound imaging. Biomaterials 2009;30:3882-3890.
25. Richard CIW, O.I.L.K., Michael H. Initial safety and myocardial perfusion imaging results with A I2700TM: A new ultrasound contrast agent. J Am Soc Echocardiogr 2001;14:455-457.
26. Ran HT, Wang ZG, Ren H, Zheng YY, Zhang QX. Research on fabrication of high molecular polymer ultrasound contrast agent for drug delivery. J Ultrasound Clin Med 2005;7:217-220.
27. Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release 2008;125:193-209.
28. Faranesh AZ, Nastley MT, Perez de la Cruz C, Haller MF, Laquerriere P, Leong KW, McVeigh ER. In vitro release of vascular endothelial growth factor from gadolinium-doped biodegradable microspheres. Magn Reson Med 2004;51:1265-1271.
29. Unger EC, Shen DK, Fritz TA. Status of liposomes as MR contrast agents. J Magn Reson Imaging 1993;3:195-198.
30. Kocbek P, Obermajer N, Cegnar M, Kos J, Kristl J. Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 2007;120:18-26. (Pubitemid 46874614)
31. Zhang XQ, Intra J, Salem AK. Conjugation of polyamidoamine dendrimers on biodegradable microparticles for nonviral gene delivery. Bioconjug Chem 2007;18:2068-2076. (Pubitemid 350220010)